Clinical Trial Update: First Line Ovarian Cancer Treatment - Cohort Study

View source ↗

Summary

This document reports on a completed cohort study evaluating first-line treatment for epithelial ovarian cancer, sponsored by ARCAGY/ GINECO.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Epithelial Ovarian Cancer | Status: COMPLETED